SYNAGEVA BIOPHARMA CORP's ticker is GEVA and the CUSIP is 87159A103.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2015 | $1,742,000 | +13.2% | 17,857 | +7.7% | 0.01% | +18.2% |
| Q4 2014 | $1,539,000 | +34.9% | 16,585 | 0.0% | 0.01% | +37.5% |
| Q3 2014 | $1,141,000 | -34.3% | 16,585 | 0.0% | 0.01% | -33.3% |
| Q2 2014 | $1,738,000 | +33.3% | 16,585 | +5.5% | 0.01% | +33.3% |
| Q1 2014 | $1,304,000 | +28.1% | 15,722 | 0.0% | 0.01% | +28.6% |
| Q4 2013 | $1,018,000 | +16.1% | 15,722 | +13.4% | 0.01% | 0.0% |
| Q3 2013 | $877,000 | +50.7% | 13,859 | 0.0% | 0.01% | +40.0% |
| Q2 2013 | $582,000 | – | 13,859 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|